Transplant Eligible | List of Frontiers open access articles

Systematic Review

Published on 13 May 2025

The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis

in Hematology

Huixing Zhou
Wenming Chen

Frontiers in Medicine

doi 10.3389/fmed.2025.1575914

4,399 views

Original Research

Published on 02 Nov 2023

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

in Hematologic Malignancies

Laura Rosiñol
Benjamin Hebraud
Albert Oriol
Anne-Laurène Colin
Rafael Ríos Tamayo
Cyrille Hulin
María Jesús Blanchard
Denis Caillot
Anna Sureda
Miguel Teodoro Hernández

Frontiers in Oncology

doi 10.3389/fonc.2023.1197340

4,740 views
12 citations

Original Research

Published on 05 Oct 2021

NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma

in NK and Innate Lymphoid Cell Biology

Ane Orrantia
Iñigo Terrén
Gabirel Astarloa-Pando
Carmen González
Alasne Uranga
Juan J. Mateos-Mazón
Juan C. García-Ruiz
Marta Riñón
Mercedes Rey
Silvia Pérez-Fernandez

Frontiers in Immunology

doi 10.3389/fimmu.2021.748207

6,124 views
23 citations

Review

Published on 26 Jan 2023

The role of transplantation in Hodgkin lymphoma

in Hematologic Malignancies

Michael Maranzano
Monica Mead

Frontiers in Oncology

doi 10.3389/fonc.2022.1054314

12,218 views
12 citations

Systematic Review

Published on 11 May 2022

First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation

in Hematologic Malignancies

Hailing Liu
Xiao Shi
Huizi Fang
Lei Cao
Yi Miao
Xiaoli Zhao
Wei Wu
Wei Xu
Jianyong Li
Lei Fan

Frontiers in Oncology

doi 10.3389/fonc.2022.881346

6,026 views
6 citations

Original Research

Published on 01 Oct 2025

Cost-effectiveness of HLX01 (Hanlikang®) vs. rituximab combined with CHOP in treatment-naive diffuse large B-Cell lymphoma: a partitioned survival model analysis

in Drugs Outcomes Research and Policies

Chang Wang
Yuanqing Huang
Langling Rao
Chunling Yu
Yingxin Zhang
Yingtao Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498735

2,974 views

Review

Published on 08 Apr 2025

Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias

in Cancer Immunity and Immunotherapy

Heather T. Morgan
Benjamin A. Derman
Hong Ma
Shaji K. Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558275

5,971 views
4 citations

Original Research

Published on 08 Jan 2026

Cost-effectiveness analysis of bridge-to-transplantation temporary mechanical circulatory support versus non-bridged heart transplantation

in Health Economics

Lei Yin
Xiuli An
Bin Yang
Zhiming Zhou
Yuhan Li
Chunhui Wang
Soumitra S. Bhuyan
Yafei Si
Pengfei Wang
Jianping Hu

Frontiers in Public Health

doi 10.3389/fpubh.2025.1687327

691 views

Original Research

Published on 05 Jul 2022

Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma

in Hematologic Malignancies

Aina Oliver-Caldes
Juan Carlos Soler-Perromat
Ester Lozano
David Moreno
Alex Bataller
Pablo Mozas
Marta Garrote
Xavier Setoain
Juan Ignacio Aróstegui
Jordi Yagüe

Frontiers in Oncology

doi 10.3389/fonc.2022.936993

6,840 views
8 citations

Original Research

Published on 21 Nov 2024

The characteristics of patients with multiple myeloma surviving over 10 years

in Hematologic Malignancies

Beihui Huang
Hongning Zhang
Junru Liu
Jingli Gu
Meilan Chen
Lifen Kuang
Xiaozhe Li
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1490630

3,479 views
2 citations

Original Research

Published on 24 Jul 2023

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma

in Hematologic Malignancies

Alicia Bao
Qiuhong Zhao
Ruchi Kudalkar
Jose Rodriguez
Nidhi Sharma
Naresh Bumma
Srinivas S. Devarakonda
Abdullah M. Khan
Elvira Umyarova
Ashley E. Rosko

Frontiers in Oncology

doi 10.3389/fonc.2023.1216461

4,439 views
1 citation

Original Research

Published on 09 May 2025

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)

in Hematologic Malignancies

Ayman Alhejazi
Ahmad Alhuraiji
Abdulnaser Nourallah
Abdulrahman Alshehri
Binyam Usman
Ghada ElGohary
Hafiz Malhan
Ibraheem Motabi
Khalil Al Farsi
Mohammed Alshuaibi

Frontiers in Oncology

doi 10.3389/fonc.2025.1547138

4,271 views

Articles

The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma

The role of transplantation in Hodgkin lymphoma

First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation

Cost-effectiveness of HLX01 (Hanlikang®) vs. rituximab combined with CHOP in treatment-naive diffuse large B-Cell lymphoma: a partitioned survival model analysis

Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias

Cost-effectiveness analysis of bridge-to-transplantation temporary mechanical circulatory support versus non-bridged heart transplantation

Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma

The characteristics of patients with multiple myeloma surviving over 10 years

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)